Labroots: ACE CancerPlus Test for DNA & RNA Sequencing for Improved Patient Outcomes

Oncologists and pathologists are increasingly utilizing information on genomic alterations in tumors to help guide patient care and treatment. Personalis, Inc., a genomic sequencing and interpretation company, has developed a tumor-profiling test that provides clinicians with accurate and comprehensive analysis and clinical reporting of 181 genes to guide treatment decisions.

Please accept preferences, statistics, marketing cookies to watch this video.